HBsAg clearance by Peg-interferon addition to a long-term nucleos(t)ide analogues therapy

• 作 者: Michele Barone Andrea Iannone
• 机 构: GastroenterologyUnitDepartmentofMedicalandSurgicalScienceUniversityofFoggia,GastroenterologyUnitDepa
• 出 处: 世界胃肠病学杂志：英文版（电子版）
• 发表日期: 2014年26期
• 关键词: ADDITION HBEAG NEGATIVE HBSAG CLEARANCE Nucleos(t) AdditionHBeAg negativeHBsAg c

The ideal endpoint of hepatitis B virus(HBV)antiviral therapy is HBsAg loss,a difficult goal to obtain,especially in HBeAg negative patients.Herein,we report the results obtained by the addition of peg-interferonα-2a to a long-lasting nucleos(t)ide analog